PNV 0.38% $2.64 polynovo limited

PNV Media Thread, page-1645

  1. 22 Posts.
    lightbulb Created with Sketch. 4
    Their literature review:
    - a porcine model
    - a mouse model
    - a case study
    - a pilot study with 5 subjects

    My previous comments stand.

    I’m fascinated at the lack of understanding amongst the group about clinical trials and regulatory submission requirements
 
watchlist Created with Sketch. Add PNV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.